Michael J. Pucci

3.8k total citations
72 papers, 3.0k citations indexed

About

Michael J. Pucci is a scholar working on Molecular Biology, Molecular Medicine and Pharmacology. According to data from OpenAlex, Michael J. Pucci has authored 72 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 35 papers in Molecular Medicine and 19 papers in Pharmacology. Recurrent topics in Michael J. Pucci's work include Antibiotic Resistance in Bacteria (35 papers), Cancer therapeutics and mechanisms (22 papers) and Antibiotics Pharmacokinetics and Efficacy (17 papers). Michael J. Pucci is often cited by papers focused on Antibiotic Resistance in Bacteria (35 papers), Cancer therapeutics and mechanisms (22 papers) and Antibiotics Pharmacokinetics and Efficacy (17 papers). Michael J. Pucci collaborates with scholars based in United States, Kenya and Germany. Michael J. Pucci's co-authors include Thomas J. Dougherty, Jane A. Thanassi, S Handwerger, Peter A. Vandenbergh, Blair S. Kunka, Barton J. Bradbury, Karen Bush, Kevin J. Volk, E. R. Vedamuthu and Nicole Cotroneo and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Applied and Environmental Microbiology.

In The Last Decade

Michael J. Pucci

71 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Pucci United States 30 1.4k 776 625 533 492 72 3.0k
Henrietta Venter Australia 31 1.4k 1.0× 1.3k 1.7× 270 0.4× 410 0.8× 395 0.8× 104 3.4k
Nathaniel I. Martin Netherlands 35 2.0k 1.5× 621 0.8× 479 0.8× 548 1.0× 286 0.6× 135 3.4k
Marta Martins Portugal 35 1.8k 1.3× 1.5k 2.0× 605 1.0× 583 1.1× 1.1k 2.2× 79 4.1k
Haihong Hao China 34 1.1k 0.8× 837 1.1× 723 1.2× 409 0.8× 424 0.9× 112 3.7k
François Malouin Canada 40 1.9k 1.4× 874 1.1× 986 1.6× 454 0.9× 1.2k 2.5× 123 4.6k
Michaele Josten Germany 28 1.5k 1.1× 264 0.3× 671 1.1× 468 0.9× 422 0.9× 49 2.8k
Luis E. N. Quadri United States 31 2.7k 2.0× 341 0.4× 876 1.4× 1.1k 2.1× 812 1.7× 55 4.2k
Sof’ya N. Senchenkova Russia 34 1.8k 1.3× 455 0.6× 608 1.0× 169 0.3× 443 0.9× 234 4.2k
Heike Brötz‐Oesterhelt Germany 33 2.6k 1.9× 554 0.7× 424 0.7× 898 1.7× 645 1.3× 88 4.3k
Anne Davin‐Regli France 28 987 0.7× 1.7k 2.3× 419 0.7× 457 0.9× 332 0.7× 56 3.2k

Countries citing papers authored by Michael J. Pucci

Since Specialization
Citations

This map shows the geographic impact of Michael J. Pucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Pucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Pucci more than expected).

Fields of papers citing papers by Michael J. Pucci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Pucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Pucci. The network helps show where Michael J. Pucci may publish in the future.

Co-authorship network of co-authors of Michael J. Pucci

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Pucci. A scholar is included among the top collaborators of Michael J. Pucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Pucci. Michael J. Pucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Critchley, Ian A., Nicole Cotroneo, Michael J. Pucci, Akash Jain, & Rodrigo E. Mendes. (2020). Resistance among urinary tract pathogens collected in Europe during 2018. Journal of Global Antimicrobial Resistance. 23. 439–444. 22 indexed citations
2.
Critchley, Ian A., Nicole Cotroneo, Michael J. Pucci, & Rodrigo E. Mendes. (2019). The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017. PLoS ONE. 14(12). e0220265–e0220265. 111 indexed citations
3.
4.
Zabawa, T. P., Michael J. Pucci, Thomas Parr, & Troy Lister. (2016). Treatment of Gram-negative bacterial infections by potentiation of antibiotics. Current Opinion in Microbiology. 33. 7–12. 86 indexed citations
5.
Ji, Cheng, Garrett C. Moraski, Jane A. Thanassi, et al.. (2012). Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels−Alder reaction. Bioorganic & Medicinal Chemistry. 20(11). 3422–3428. 6 indexed citations
6.
Bush, Karen & Michael J. Pucci. (2011). New antimicrobial agents on the horizon. Biochemical Pharmacology. 82(11). 1528–1539. 43 indexed citations
7.
Moraski, Garrett C., Jane A. Thanassi, Steven D. Podos, Michael J. Pucci, & Marvin J. Miller. (2011). One-step syntheses of nitrofuranyl benzimidazoles that are active against multidrug-resistant bacteria. The Journal of Antibiotics. 64(10). 667–671. 11 indexed citations
8.
Aboul‐Fadl, Tarek, Hatem A. Abdel‐Aziz, Mohammed K. Abdel‐Hamid, et al.. (2011). Schiff Bases of Indoline-2,3-dione: Potential Novel Inhibitors of Mycobacterium Tuberculosis (Mtb) DNA Gyrase. Molecules. 16(9). 7864–7879. 42 indexed citations
9.
Bradbury, Barton J. & Michael J. Pucci. (2008). Recent advances in bacterial topoisomerase inhibitors. Current Opinion in Pharmacology. 8(5). 574–581. 80 indexed citations
10.
Pucci, Michael J.. (2007). Novel Genetic Techniques and Approaches in the Microbial Genomics Era. Drugs in R&D. 8(4). 201–212. 12 indexed citations
11.
Agarwal, Atul, Shirley Louise‐May, Jane A. Thanassi, et al.. (2007). Small molecule inhibitors of E. coli primase, a novel bacterial target. Bioorganic & Medicinal Chemistry Letters. 17(10). 2807–2810. 38 indexed citations
12.
Pucci, Michael J. & Thomas J. Dougherty. (2007). A Method to Assay Penicillin-Binding Proteins. Methods in molecular medicine. 142. 131–141. 1 indexed citations
13.
Pucci, Michael J.. (2006). Use of genomics to select antibacterial targets. Biochemical Pharmacology. 71(7). 1066–1072. 36 indexed citations
14.
15.
Regueiro‐Ren, Alicia, B. Narasimhulu Naidu, Xiaofan Zheng, et al.. (2003). Novel semi-synthetic nocathiacin antibiotics: synthesis and antibacterial activity of bis- and mono-O-alkylated derivatives. Bioorganic & Medicinal Chemistry Letters. 14(1). 171–175. 29 indexed citations
16.
Discotto, Linda, Michael J. Pucci, Laura Lawrence, & John F. Barrett. (1998). 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 24-27, 1998, San Diego, CA, USA. Expert Opinion on Investigational Drugs. 7(12). 2061–2077. 2 indexed citations
17.
Frosco, MaryBeth, Michael J. Pucci, Laura Lawrence, et al.. (1997). The 97th Annual Meeting of the American Society for Microbiology. Expert Opinion on Investigational Drugs. 6(7). 899–813. 9 indexed citations
18.
Falk, Paul, Kerry M. Ervin, Bala Krishnan, et al.. (1995). UDP-N-acetylmuramyl-L-alanine Functions as an Activator in the Regulation of the Escherichia coli Glutamate Racemase Activity. Biochemistry. 34(8). 2464–2470. 26 indexed citations
19.
Volk, Kevin J., et al.. (1994). Binding Studies of Vancomycin to the Cytoplasmic Peptidoglycan Precursors By Affinity Capillary Electrophoresis. Analytical Chemistry. 66(14). 2412–2416. 82 indexed citations
20.
Pucci, Michael J., et al.. (1991). Comparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329. Antimicrobial Agents and Chemotherapy. 35(11). 2312–2317. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henrietta Venter Breakdown of academic impact, for papers by Nathaniel I. Martin Breakdown of academic impact, for papers by Marta Martins Breakdown of academic impact, for papers by Haihong Hao Breakdown of academic impact, for papers by François Malouin Breakdown of academic impact, for papers by Michaele Josten Breakdown of academic impact, for papers by Luis E. N. Quadri Breakdown of academic impact, for papers by Sof’ya N. Senchenkova Breakdown of academic impact, for papers by Heike Brötz‐Oesterhelt Breakdown of academic impact, for papers by Anne Davin‐Regli
Rankless by CCL
2026